25.96

2.41% -0.60

Hims Hers Health Inc (HIMS)

Overview News Price History Option Chain Financials Why HIMS Down? Discussions Forecast

Hims Hers Health Inc stock is traded at $25.96, with a volume of 5.34M. It is down -2.41% in the last 24 hours and down -19.55% over the past month. Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Previous Close:

$26.56

Open:

$25.54

24h Volume:

5.34M

Relative Volume:

0.33

Market Cap:

$5.49B

Revenue:

$1.24B

Net Income/Loss:

$101.26M

P/E Ratio:

-152.71

EPS:

-0.17

Net Cash Flow:

$149.62M

1W Performance:

-6.09%

1M Performance:

-19.55%

6M Performance:

+28.38%

1Y Performance:

+191.24%

1-Day Range:

$25.01

$26.11

1-Week Range:

$25.01

$30.23

52-Week Range:

$8.09

$35.02

Hims Hers Health Inc Stock (HIMS) Company Profile

Name

Hims Hers Health Inc

Sector

Consumer Defensive (250)

Industry

Household & Personal Products (29)

Phone

415-851-0195

Address

2269 CHESTNUT ST, SAN FRANCISCO

Employee

1,046

Twitter

Next Earnings Date

2024-11-04

Latest SEC Filings

HIMS's Discussions on Twitter

Compare HIMS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HIMS Hims Hers Health Inc	25.96	5.49B	1.24B	101.26M	149.62M	0.44
PG Procter Gamble Co	167.44	393.19B	83.91B	14.32B	15.85B	5.80
UL Unilever Plc Adr	56.78	142.11B	64.93B	7.15B	0	2.832
CL Colgate Palmolive Co	90.77	74.17B	20.11B	2.87B	3.40B	3.49
KMB Kimberly Clark Corp	130.65	43.31B	20.10B	2.61B	2.90B	7.71
KVUE Kenvue Inc	21.32	40.70B	15.46B	1.06B	1.40B	0.55

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Initiated	Morgan Stanley	Overweight
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral
Apr-16-24	Downgrade	Jefferies	Buy → Hold
Apr-10-24	Initiated	Canaccord Genuity	Buy
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform
Feb-26-24	Initiated	Leerink Partners	Market Perform
Dec-07-23	Initiated	Imperial Capital	In-line
Jul-28-23	Initiated	TD Cowen	Outperform
Apr-11-23	Initiated	Robert W. Baird	Neutral
Feb-09-23	Upgrade	Jefferies	Hold → Buy
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform
Oct-17-22	Downgrade	Piper Sandler	Overweight → Neutral
Sep-07-22	Initiated	Truist	Hold
Jul-15-22	Initiated	SVB Leerink	Underperform
Apr-14-22	Initiated	Guggenheim	Buy
Apr-01-22	Resumed	Credit Suisse	Outperform
Mar-10-22	Initiated	Deutsche Bank	Hold
Dec-02-21	Initiated	Jefferies	Hold
Nov-11-21	Upgrade	Piper Sandler	Neutral → Overweight
Jul-06-21	Initiated	BofA Securities	Neutral
May-20-21	Upgrade	Credit Suisse	Neutral → Outperform
Apr-21-21	Initiated	Truist	Hold
Mar-09-21	Initiated	Credit Suisse	Neutral
Mar-02-21	Upgrade	Citigroup	Neutral → Buy
Feb-17-21	Initiated	Citigroup	Neutral
Feb-12-21	Initiated	Piper Sandler	Neutral
Feb-08-21	Initiated	Tigress Financial	Buy

View All

Hims Hers Health Inc Stock (HIMS) Latest News

10:56 AM

Hims & Hers Health (NYSE:HIMS) Shares Gap Down After Insider Selling - MarketBeat

10:56 AM

Dec 28, 2024

Market Slump Drags Down Share Prices of Hims & Hers Health Inc. (HIMS) - Insider Monkey

Dec 28, 2024